GoldenGolden
Indee Labs

Indee Labs

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

All edits by  Will Suter 

Edits on 26 May, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 26 May, 2019
Edits made to:
Article (+22/-22 characters)
Article

In May 2018, Indee Labs closed out a seed round resulting in USD$2.6M in angel and venture financing from Founders Fund, Main Sequence VenturesMain Sequence Ventures, Social+Capital also among others.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.